Dr. Lal PathLabs Upgraded by CARE Ratings
Dr. Lal PathLabs Ltd. has received a credit rating upgrade from CARE Ratings Limited, as announced on March 25, 2026. The company’s Issuer Rating has been upgraded to CARE AA+; Stable, from the previous rating of CARE AA; Stable.According to CARE Ratings, the upgrade is based on the company’s operational and financial performance for the fiscal year 2025 (audited) and the nine-month period of fiscal year 2026 (unaudited).
The rating agency emphasized that the rating represents an opinion on the company’s general creditworthiness and is not specific to any particular debt instrument. CARE Ratings reserves the right to review the rating periodically.
| Type of Rating | Rating | Rating Action |
|---|---|---|
| Issuer Rating | CARE AA+; Stable | Upgraded from CARE AA; Stable |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.